Inturai Ventures Corp.

As of March 31, 2026, Inturai Ventures Corp. carries a market capitalization of 23.22M, placing it among publicly traded companies globally. Its enterprise value stands at 22.63M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Inturai Ventures Corp. has 122.23M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Inturai Ventures Corp. maintains a current ratio of 4.48, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, Inturai Ventures Corp. posted a negative return on equity (ROE) of -169.44, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -154.74, reflecting losses generated across the asset base.

Over the twelve months ended March 31, 2026, Inturai Ventures Corp. generated - - in revenue and converted that into -2.52M in net income, yielding earnings per share of -0.02. EBITDA reached -2.50M, while operating income came in at -2.50M.

These figures are as of March 31, 2026. Total book value stands at 1.35M, with working capital of 541,645.00 providing operational flexibility.

Inturai Ventures Corp. produced -2.26M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -2,344.00 in capital expenditures, free cash flow totaled -2.26M - equivalent to -0.02 per share.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -9.77: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -8.73, meaning Inturai Ventures Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of March 31, 2026, Inturai Ventures Corp. has an Altman Z-Score of 69.33, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.